Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling Pathway
Yue Zhou,Ai-Qing Nie,Shang Chen,Meng-Meng Wang,Rui Yin,Bo-Hao Tang,Yue-E Wu,Fan Yang,Bin Du,Hai-Yan Shi,Xin-Mei Yang,Guo-Xiang Hao,Xiu-Li Guo,Qiu-Ju Han,Yi Zheng,Wei Zhao
DOI: https://doi.org/10.2147/jir.s310687
IF: 4.5
2021-05-26
Journal of Inflammation Research
Abstract:Yue Zhou, 1 Ai-Qing Nie, 1 Shang Chen, 2 Meng-Meng Wang, 1 Rui Yin, 1 Bo-Hao Tang, 1 Yue-E Wu, 1 Fan Yang, 1 Bin Du, 1 Hai-Yan Shi, 3 Xin-Mei Yang, 3 Guo-Xiang Hao, 1 Xiu-Li Guo, 4 Qiu-Ju Han, 5 Yi Zheng, 1, * Wei Zhao 1, 3, * 1 Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China; 2 Institute of Biochemical and Biotechnological Drug, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China; 3 Department of Pharmacy, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, People's Republic of China; 4 Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China; 5 Institute of Immunopharmaceutical Sciences, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China *These authors contributed equally to this work Correspondence: Yi Zheng; Wei Zhao Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, No. 44, Wenhua West Road, Jinan, Shandong Province, People's Republic of China Tel/Fax +86 531 8838 3308 Email ; Purpose: Considering prior investigations on reductions of renal multidrug resistance-associated protein (MRP) 2 and 4 transporters in mice with acute lymphoblastic leukemia (ALL), we sought to characterize the underlying mechanisms responsible for IL-6/STAT3/PXR-mediated changes in the expression of MRP2 and MRP4 in ALL. Subjects and Methods: ALL xenograft models were established and intravenously injected with methotrexate (MTX) of MRPs substrate in NOD/SCID mice. Protein expression of MRPs and associated mechanisms were detected by Western blotting and immunocytochemistry. Plasma concentrations of MTX were determined using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Results: Plasma IL-6 levels in patients with newly diagnosed ALL were increased compared to children with pneumonia. Similarly, plasma IL-6 levels in ALL, ALL-tocilizumab (TCZ, an IL-6 receptor inhibitor) and ALL-S3I-201 (a selective inhibitor of STAT3) mice were increased compared to the control group. The MRP2, MRP4, and PXR expression in HK-2 cells treated with IL-6 were decreased, whereas the p-STAT3 expression was significantly increased compared to the control group results. These results are consistent with clearance of MRPs-mediated MTX in the ALL group. These effects were attenuated by blocking IL-6/STAT3/PXR signaling pathway. Conclusion: Inflammation-mediated changes in pharmacokinetics are thought to be executed through pathways IL-6-activated pathways, which can facilitate a better understanding of the potential for the use of IL-6 to predict the severity of adverse outcomes and the major implications on potential ALL treatments. Keywords: disease-induced pharmacokinetic change, renal transporters, inflammatory cytokines, clearance Renal proximal tubules play a crucial role in salt absorbance, water dynamics, and in the mechanistic of organic anions such as glucose from the glomerular filtrate. Further, these tubules help to eliminate endogenous and exogenous waste products from the body. Of all known transporters that function in the kidney, multidrug resistance-associated protein (MRP) transporters MRP2/4 are essential. For example, MRP2/4 are major determinants of the apical efflux of organic anions into the tubular lumen, including β-lactams, antivirals, diuretics, NSAIDs, and methotrexate (MTX). 1–4 Thus, MRP2/4 contributes to intracellular drug concentrations and chemotherapeutic effects. In prior research composed by some of us, kidney tissues from mice afflicted by acute lymphoblastic leukemia (ALL) exhibited decreased mRNA and protein levels of MRP2/4, as well as decreased efficiencies in the transporter functions. 5 However, regulatory mechanisms of the MRP2/4 proteins remain unclear concerning ALL-affected mice kidneys. The expression of drug transporters is subject to transcriptional regul -Abstract Truncated-
immunology